Depression
Showing NaN - NaN of 24
Bipolar I Disorder, Mania, Depression Trial in Worldwide (Cariprazine, Placebo)
Completed
- Bipolar I Disorder
- +2 more
- Cariprazine
- Placebo
-
Little Rock, Arkansas
- +111 more
Dec 12, 2022
MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)
Completed
- Major Depressive Disorder
- +2 more
- AXS-05 (dextromethorphan and bupropion) oral tablets
-
Phoenix, Arizona
- +50 more
Sep 16, 2022
Depression, Bipolar I Disorder Trial in Worldwide (Cariprazine, Placebo)
Recruiting
- Depression
- Bipolar I Disorder
- Cariprazine
- Placebo
-
Bentonville, Arkansas
- +51 more
Aug 22, 2022
Depression, MDD Trial in United States (AXS-05, Placebo)
Completed
- Depression
- Major Depressive Disorder
- AXS-05
- Placebo
-
Phoenix, Arizona
- +42 more
Sep 22, 2021
Liver Cancer, Anxiety Disorder, Depression Trial in United States (Early palliative care)
Completed
- Liver Cancer
- +9 more
- Early palliative care
-
La Jolla, California
- +22 more
Jul 22, 2021
Bipolar Disorder, Depression Trial in Worldwide (Cariprazine, Placebo)
Bipolar Disorder, Depression Trial in Worldwide (Cariprazine, Placebo)
Completed
- Bipolar Disorder
- Depression
- Cariprazine
- Placebo
-
Little Rock, Arkansas
- +73 more
Jan 10, 2019
Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (OPC-34712, Escitalopram, Fluoxetine)
Sexual Dysfunctions, Psychological, Depression Trial in United States (flibanserin 50 mg to 100 mg qhs, flibanserin 100 mg qhs,
Terminated
- Sexual Dysfunctions, Psychological
- Depression
- flibanserin 50 mg to 100 mg qhs
- +2 more
-
Costa Mesa, California
- +41 more
Jul 14, 2016
Depression Trial in United States (EVT 101, Placebo)
Terminated
- Depression
- EVT 101
- Placebo
-
Oceanside, California
- +13 more
Mar 1, 2016
COPD, Heart Failure, Anxiety Trial in Oklahoma City, Houston (ACCESS)
Completed
- Chronic Obstructive Pulmonary Disease
- +3 more
- ACCESS
-
Oklahoma City, Oklahoma
- +1 more
Jan 25, 2016
Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (OPC-34712 + ADT, Placebo + ADT)
Completed
- Depressive Disorder
- +4 more
- OPC-34712 + ADT
- Placebo + ADT
-
Birmingham, Alabama
- +70 more
Nov 30, 2015
Depression Trial in Worldwide (Placebo matching with BMS-820836, BMS-820836)
Terminated
- Depression
- Placebo matching with BMS-820836
- BMS-820836
-
Birmingham, Alabama
- +143 more
Sep 23, 2015
MDD, Depression Trial in India, Puerto Rico, United States (TC-5214, Placebo)
Completed
- Major Depressive Disorder
- Depression
- TC-5214
- Placebo
-
Birmingham, Alabama
- +98 more
Mar 14, 2014
Depression Trial in United States (Venlafaxine XR, Placebo, JNJ26489112)
Terminated
- Depression
- Venlafaxine XR
- +2 more
-
Arcadia, California
- +13 more
Feb 11, 2013
Depression, Depressive Disorder, Depressive Disorder, Major Trial in United States (Desvenlafaxine administered as a succinate
Completed
- Depression
- +2 more
- Desvenlafaxine administered as a succinate salt in a sustained-release form (DVS SR)
- Placebo
-
Birmingham, Alabama
- +36 more
Apr 9, 2012
Depression Trial in United States (blood draw)
Completed
- Depression
- blood draw
-
Birmingham, Alabama
- +52 more
Jan 5, 2011
Depression, Depressive Disorder, Depressive Disorder, Major Trial in Worldwide (Desvenlafaxine succinate sustained-release (DVS
Completed
- Depression
- +2 more
- Desvenlafaxine succinate sustained-release (DVS SR)
- Escitalopram
-
Peoria, Arizona
- +69 more
May 26, 2010